Vivimed Labs Q2 FY2023 consolidated loss at Rs. 22.03 Cr

The company has reported total income of Rs. 44.37 crores during the period ended September 30, 2022

Eugia Pharma receives USFDA approval for Amphotericin B Liposome for Injection

The product is expected to be launched by Q4 FY23.

Strand Life Sciences launches ‘Strand Genomic Wellness’

Strand’s new offering will help people better understand and manage diseases through genomic sequencing

Zydus Lifesciences gets exclusive marketing rights for CanAssist Breast

Zydus becomes the only Indian oncology player to venture into prognosis and diagnosis along with treatment planning

Cadila recognized for its contribution to leprosy treatment

Cadila Pharmaceuticals was felicitated during the plenary session of the 21st International Leprosy Congress

IOL Chemicals and Pharmaceuticals Q2FY23 net profit drops to Rs 15.6 Cr

The company registered with REACH Certificate for Ethyl Acetate with a tonnage band of more than 1000 TPA

Orchid Pharma reports positive EBIDTA in Q2

The company is focussed on increasing the capacity utilizations while controlling costs

Strong order book in CMO segments for J.B. Chemicals & Pharmaceuticals, says Prabhudas Lilladher

The company sees the business reaching $100mn

SMS Pharma revenue down 9%

Within the API segment, ~20% of the revenues came from the domestic market and ~80% from the exports market

Biocon Q2FY23 net profit slips 10% to Rs 168 Cr; Revenue up 26%